Literature DB >> 8109822

Immunosuppressive profile of rapamycin.

S N Sehgal1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8109822     DOI： 10.1111/j.1749-6632.1993.tb17136.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.

Authors:  J E Kay; M C Smith; V Frost; G Y Morgan
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 2.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.

Authors:  Sofia Sofroniadou; David Goldsmith
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

4.  Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.

Authors:  Morihito Takita; Shinichi Matsumoto; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Jeffrey A Sorelle; Kerri Purcell; Nicholas Onaca; Bashoo Naziruddin; Marlon F Levy
Journal:  Clin Transplant       Date:  2012 Sep-Oct       Impact factor: 2.863

5.  Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake.

Authors:  Robert Laplanche; Guy M L Meno-Tetang; Ryosei Kawai
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-03-13       Impact factor: 2.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.